These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8053353)

  • 1. [Comparison of the effect of amisulpride and viloxazine in the treatment of dysthymia].
    León CA; Vigoya J; Conde S; Campo G; Castrillón E; León A
    Acta Psiquiatr Psicol Am Lat; 1994 Mar; 40(1):41-9. PubMed ID: 8053353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
    Amore M; Jori MC;
    Int Clin Psychopharmacol; 2001 Nov; 16(6):317-24. PubMed ID: 11712619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
    Cassano GB; Jori MC;
    Int Clin Psychopharmacol; 2002 Jan; 17(1):27-32. PubMed ID: 11800503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(5):293-8. PubMed ID: 2079386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group.
    Lecrubier Y; Boyer P; Turjanski S; Rein W
    J Affect Disord; 1997 Apr; 43(2):95-103. PubMed ID: 9165379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.
    Smeraldi E
    J Affect Disord; 1998 Feb; 48(1):47-56. PubMed ID: 9495601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1504-9. PubMed ID: 17692448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
    Petrie WM; McEvoy JP; Wilson WH; Ban TA; Guy W
    Int Pharmacopsychiatry; 1980; 15(3):193-6. PubMed ID: 7016802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of some schizophrenic deficit symptoms with low doses of amisulpride.
    Paillère-Martinot ML; Lecrubier Y; Martinot JL; Aubin F
    Am J Psychiatry; 1995 Jan; 152(1):130-4. PubMed ID: 7802104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness.
    Sedman G
    Curr Med Res Opin; 1977; 5(3):217-25. PubMed ID: 162657
    [No Abstract]   [Full Text] [Related]  

  • 12. A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.
    Magnus RV
    J Int Med Res; 1975; 3(3):207-13. PubMed ID: 162677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
    Montgomery SA
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
    Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
    Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double blind comparison of the antidepressives viloxazine and imipramine (author's transl)].
    Pöldinger W
    Dtsch Med Wochenschr; 1982 Apr; 107(17):661-5. PubMed ID: 7075479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viloxazine: an assessment of its potential rapid antidepressant action and unwanted effects.
    Edwards JG
    Curr Med Res Opin; 1977; 5(3):226-33. PubMed ID: 162658
    [No Abstract]   [Full Text] [Related]  

  • 18. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators.
    Ravizza L
    J Psychopharmacol; 1999; 13(3):248-54. PubMed ID: 10512080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does viloxazine really improve sex drive? A double-blind controlled study.
    De Leo D; Magni G
    Br J Psychiatry; 1986 May; 148():597-9. PubMed ID: 3535972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.